SteadyMed Ltd. is a medical-device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.
The company's products are pre-filled drug-infusion patches that will be sold in conjunction with a series of pharma and device companies. Specific applications of the device will be tailored in accordance with the requirements of the company's partners.
Funding Rounds (5) - $59.6MUpdate
Current Team (7)Update
|Aug 1, 2016||globes.co.il - Drug developer SteadyMed raises $32m|
|Jul 25, 2016||ir.steadymed.com - Press Releases|
|Jan 18, 2016||PE HUB - MVPindex nabs $7 mln Series A|
|Oct 5, 2015||equities.com - IPO Report: SteadyMed (STDY) - Equities.com - Global Financial Community|
|Oct 5, 2015||globes.co.il - SteadyMed Therapeutics raises $40m in Nasdaq IPO - Globes English|
|Sep 16, 2015||Mass Device - SynCardia sets terms for $28m IPO|
|Sep 15, 2015||Mass Device - Losses widening, Unilife pares workforce by 17%|
|Mar 20, 2015||Boston Tech Flash - SteadyMed raises $40M in IPO that falls far short of expectations - Silicon Valley Business Journal|
5 Oppenheimer St,
22 Raul Wallenberg St
Tel Aviv, 69719